Description
Hepargrizovim I.M. Ampul emerges as a medicinal solution designed for intramuscular administration. This elixir of well-being encapsulates a harmonious blend of vital vitamins, including Cyanocobalamin (Vitamin B12), Nicotinamide (PP Vitamin), Folic Acid, and Ascorbic Acid (Vitamin C). Each of these constituents plays a pivotal role in fostering health and vitality.
Ingredients
Hepargrizovim I.M. Ampul stands as a testament to meticulous pharmaceutical craftsmanship. Its composition is a tale of precision:
Ampule Type I (1 ml ampule):
- Cyanocobalamin (Vitamin B12): 2.50 mg
- Nicotinamide (PP Vitamin): 12.00 mg
- Folic Acid: 0.70 mg
Ampule Type II (2 ml ampule):
- Ascorbic Acid (Vitamin C): 150.00 mg
In addition to its core components, Hepargrizovim I.M. Ampul incorporates auxiliary substances to ensure stability and efficacy. In Ampule Type I, Sodium Tartrate lends its support, while Ampule Type II boasts the presence of Sodium Bicarbonate and Sodium Hydrosulfite.
Hepargrizovim I.M. Ampul Indications
The application spectrum of Hepargrizovim I.M. Ampul is diverse, catering to an array of healthcare needs. This medication serves as a trusted ally in addressing:
- Protein-poor Nutritional States
- Vitamin B12 Deficiencies Resulting from Gastrectomy and Malabsorption
- Pernicious Anemia
- Debilitating Diseases, Severe Fatigue, Convalescence
- Postoperative Hypoproteinemia
- Hyperchromic Anemia Resistant to Treatment with Vitamin B12 Alone
- Neuralgia, Especially Trigeminal Neuralgia
Contradictions
While Hepargrizovim I.M. Ampul holds the promise of therapeutic benefits, it bears certain contradictions that must be acknowledged. This medication should be avoided by individuals with:
- Known or Suspected Hypersensitivity to Any of Its Components
- Optic Neuropathy
Precautions
The path to well-being should always be paved with caution. Here are essential precautions to consider:
Patients with Diabetes or Hyperoxaluria:
- Utilize Hepargrizovim I.M. Ampul with Prudence.
Sulfite Sensitivity:
- This medication incorporates sulfite as a preservative, which can induce severe allergic reactions in sensitive individuals, with potential exacerbation in asthmatic patients.
Allergic Reactions:
- Be vigilant, as allergic reactions may manifest in response to Vitamin B12.
Urinary Redness:
- The use of Hepargrizovim I.M. Ampul may impart a reddish hue to urine.
Blood Glucose Concentrations:
- Diabetic patients utilizing nicotinic acid or nicotinamide should undergo periodic monitoring of blood glucose concentrations, as requirements for antidiabetic agents may fluctuate.
Fainting or Dizziness:
- Caution is warranted during the rapid intravenous administration of ascorbic acid, as it can precipitate fainting or dizziness.
Dosage
The recommended dosage of Hepargrizovim I.M. Ampul for adults typically encompasses 2-3 injections per week. However, in severe or specialized cases, this frequency may escalate to 1-2 injections per day. Administration involves drawing one red and one colorless ampoule into the same injector and delivering it intramuscularly under the guidance of a healthcare provider.
Please note that individual dosages may fluctuate based on specific medical conditions and responses to the medication. Adherence to the directives of your healthcare provider is paramount for optimizing therapeutic outcomes.
Children and the Elderly
The usage of Hepargrizovim I.M. Ampul in children and the elderly remains a topic not explicitly addressed in available sources. It’s important to recognize that many medications intended for adult use have not undergone rigorous testing in these age groups. As such, any application of this medication in children or the elderly should transpire under the vigilant oversight of a healthcare provider. Prior to prescribing, healthcare providers meticulously weigh the benefits against the potential risks, ensuring the safest course of action.
Off-Label Possibilities
While the formalized applications of Hepargrizovim I.M. Ampul are well-defined, the realm of medicine often witnesses the practice of off-label usage. This term denotes the prescription of a drug for purposes beyond its formal approval. While this practice hinges on robust clinical evidence, it mandates the careful guidance of a healthcare provider. Before embarking on the journey of off-label use, healthcare providers meticulously evaluate the benefits and potential risks to chart the safest course of action.
In conclusion, Hepargrizovim I.M. Ampul embodies a multifaceted medication replete with essential vitamins and therapeutic potential. However, its usage must be underpinned by a deep understanding of its composition, contraindications, and precautions. Your healthcare provider remains the steadfast beacon guiding you through the labyrinth of healthcare decisions
At a glance
| Medication Name | Hepargrizovim I.M. Ampul |
|---|---|
| Active Ingredients | – Cyanocobalamin (Vitamin B12) |
| – Nicotinamide (PP Vitamin) | |
| – Folic Acid | |
| – Ascorbic Acid (Vitamin C) | |
| Dosage per Ampule | – 1 ml Ampule: |
| – Cyanocobalamin (Vitamin B12): 2.50 mg | |
| – Nicotinamide (PP Vitamin): 12.00 mg | |
| – Folic Acid: 0.70 mg | |
| – 2 ml Ampule: | |
| – Ascorbic Acid (Vitamin C): 150.00 mg | |
| Auxiliary Substances | – Ampule Type I: |
| – Sodium Tartrate | |
| – Ampule Type II: | |
| – Sodium Bicarbonate | |
| – Sodium Hydrosulfite | |
| Indications | – Protein-Poor Nutritional States |
| – Vitamin B12 Deficiencies Resulting from Gastrectomy and Malabsorption | |
| – Pernicious Anemia | |
| – Debilitating Diseases, Severe Fatigue, Convalescence, Postoperative Hypoproteinemia | |
| – Hyperchromic Anemia Resistant to Treatment with Vitamin B12 Alone | |
| – Neuralgia, Especially Trigeminal Neuralgia | |
| Contraindications | – Known or Suspected Hypersensitivity to Any of Its Components |
| – Optic Neuropathy | |
| Precautions | – Diabetes or Hyperoxaluria: Use with Caution |
| – Sulfite Sensitivity: Potential for Allergic Reactions, Exacerbated in Asthmatic Patients | |
| – Allergic Reactions: Possible in Response to Vitamin B12 | |
| – Urinary Redness: May Cause Reddish Urine | |
| – Blood Glucose Concentrations: Monitoring Required for Diabetic Patients Using Nicotinic Acid or Nicotinamide | |
| – Fainting or Dizziness: Risk with Rapid IV Administration of Ascorbic Acid | |
| Dosage and Administration | – Adults: Typically 2-3 Injections per Week, May Increase to 1-2 Injections per Day in Special Cases |
| – Administer One Red and One Colorless Ampoule Intramuscularly | |
| Usage in Children/Elderly | Not Explicitly Addressed, Healthcare Provider Supervision Recommended |
| Off-Label Usage | Practice Guided by Healthcare Provider Based on Clinical Evidence |
Reviews
There are no reviews yet.